Fursultiamine was synthesized for the purpose of developing forms of thiamine with improved lipophilicity for treating vitamin B1 deficiency. In addition to its clinical indication of avitaminosis, fursultiamine has been studied in clinical trials for Alzheimer’s disease and autistic spectrum disorders with positive but modest benefits. It has also been investigated in improving energy metabolism during exercise and reducing exercise-induced fatigue with conflicting results.
Dangerous Goods Info:
Miura, S.: Nippon Ganka Gakkai Zasshi, 69, 792 (1965); Mimori, Y., et al.: Met. Brain Disease, 11, 89 (1996); Webster, M., et al.: Eur. J. Appl. Physiol. Occup. Physio., 75, 520 (1997)